Dosing and Administration Typical Dose : 1.25 mg to 2 mg (0.250.4 mL) per dose Administration : Intranasal spray in one or both nostrils , as directed Timing : Use 1530 minutes before anticipated sexual activity Frequency : No more than 1 dose per 24-hour period
This medication works by binding to two receptors (GLP-1 and GIP) simultaneously to suppress appetite, support weight loss, and promote metabolic health
Other statin drugs, such as rosuvastatin and fluvastatin, can increase GSH and/or GPX in the myocardium to alleviate ISO-mediated myocardial injury [230, 231]
One important change is that they state, GLP-1 RA therapy may be continued preoperatively in patients without elevated risk of delayed gastric emptying. The risk factors they state include: escalation phase of dosing, higher dose, weekly dosing (as opposed to daily dosing), gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, constipation), and medical conditions that may cause delayed gastric emptying